INTERPACE BIOSCIENCES, INC. (IDXG) › Capital ExpendituresINTERPACE BIOSCIENCES, INC. (IDXG) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $2.13M2011: $343.0K2012: $1.11M2013: $1.82M2014: $2.85M2015: $353.0K2017: $29.0K2018: $449.0K2019: $131.0K2020: $1.57M2021: $354.0K2022: $322.0K2023: $470.0K2024: $876.0K2025: $356.0K$356.0K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$356.0K-59.4%2024$876.0K+86.4%2023$470.0K+46.0%2022$322.0K-9.0%2021$354.0K-77.5%2020$1.57M+1102.3%2019$131.0K-70.8%2018$449.0K+1448.3%2017$29.0K—2015$353.0K-87.6%2014$2.85M+56.8%2013$1.82M+63.5%2012$1.11M+224.2%2011$343.0K-83.9%2010$2.13M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share